Publication date: Dec 31, 2024
The COVID-19 pandemic was a significant health risk and resulted in increased sickness absence during the pandemic. This study examines whether a history of COVID-19 infection is associated with a higher risk of subsequent sickness absence. In this prospective cohort study, 32,124 public sector employees responded to a survey on COVID-19 infection and lifestyle factors in 2020 and were linked to sickness absence records before (2019) and after (2021-2022) the survey. Study outcome was annual sickness absence defined as the total number of sickness absence days and the number of short sickness absence spells (
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | infection |
| disease | IDO | history |
| disease | MESH | lifestyle factors |
| pathway | REACTOME | Reproduction |
| disease | MESH | morbidity |
| drug | DRUGBANK | Serine |
| drug | DRUGBANK | L-Citrulline |
| drug | DRUGBANK | Indoleacetic acid |
| drug | DRUGBANK | Ethanol |
| drug | DRUGBANK | Methionine |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | long COVID |
| disease | IDO | susceptibility |
| disease | MESH | arrythmia |
| disease | MESH | peripheral neuropathy |
| disease | MESH | anxiety |
| disease | MESH | infectious diseases |
| disease | MESH | physical inactivity |
| disease | MESH | symptom clusters |
| drug | DRUGBANK | Guanosine |
| disease | MESH | sequelae |
Original Article
(Visited 1 times, 1 visits today)